Progress in Research on Stem Cells in Neonatal Refractory Diseases

Area of Science:

• Neonatal Medicine
• Regenerative Medicine
• Cell Biology

Background:

• Medical advancements increase survival rates of premature infants, leading to a rise in serious neonatal diseases.
• Conditions such as hypoxic-ischemic encephalopathy and necrotizing enterocolitis have poor prognoses with current treatments.
• Stem cells possess self-renewal and differentiation capabilities, offering therapeutic potential through anti-inflammatory, anti-apoptotic, and regenerative mechanisms.

Purpose of the Study:

• To review the current research on stem cell and exosome therapy for refractory neonatal diseases.
• To provide insights into the potential of stem cell-based treatments for neonatal conditions.
• To discuss existing challenges and future perspectives in stem cell therapy for neonates.

Main Methods:

• Literature review of studies on stem cells and exosomes in neonatal diseases.
• Analysis of stem cell mechanisms including paracrine effects, anti-inflammatory, and regenerative properties.
• Examination of research progress in applying stem cell therapy to neonatal refractory diseases.

Main Results:

• Stem cells and their derived exosomes exhibit therapeutic potential via anti-inflammatory, anti-apoptotic, and regenerative effects.
• Paracrine actions of stem cells can modulate the microenvironment, influencing cellular behavior.
• Research indicates stem cell therapy could offer novel treatment avenues for severe neonatal conditions.

Conclusions:

• Stem cell therapy, including the use of exosomes, presents a promising frontier for managing severe neonatal diseases.
• Further research and clinical trials are needed to overcome challenges and realize the full potential of stem cell treatments in neonatology.
• This review highlights the need for continued investigation into stem cell mechanisms and applications for improved neonatal outcomes.